Celltrion Expands Facilities for Next-Gen Obesity Therapies

-

Expansion of U.S. and Korean Production Facilities

Chairman Seo Jeong-jin of Celltrion Group has unveiled ambitious plans to expand production facilities in both the United States and South Korea. This strategic move is aimed at meeting rising global demand for pharmaceuticals while mitigating potential risks associated with tariffs and supply chain challenges.

During an online press briefing, Chairman Seo highlighted that the acquisition of Eli Lilly’s biopharmaceutical production facility in Branchburg, New Jersey, will be finalized within this year. Once completed, the company intends to maximize the facility's production capacity to ensure efficiency. He emphasized that this step will eliminate tariff risks for pharmaceuticals supplied to the U.S. market, allowing Celltrion to better respond to the growing global demand.

In addition to the U.S. expansion, Celltrion is also planning significant upgrades to its domestic facilities. The company aims to add six 11,000L bioreactors in two phases, increasing total capacity by 66,000L. When fully operational, the total production capacity will reach 132,000L, with an estimated investment of up to 700 billion Korean won. Earlier in September, Celltrion signed a 460 billion Korean won agreement with Eli Lilly for the facility.

The company is also accelerating the establishment of new domestic production facilities. Alongside the liquid finished pharmaceutical (DP) plant currently under construction in Songdo Campus, Celltrion plans to build:

  • A new active pharmaceutical ingredient (API) plant in Songdo, Incheon
  • A new finished pharmaceutical plant in Yesan, South Chungcheong Province
  • A pre-filled syringe production plant in Ochang, North Chungcheong Province

This extensive development project is expected to require an investment of approximately 4 trillion Korean won.

Developing Next-Generation Obesity Treatments

Celltrion is also making significant strides in the development of next-generation obesity treatments. Chairman Seo explained that current treatments in development focus on dual or triple agonists, including GLP-1. However, the company is advancing an oral model that targets four mechanisms simultaneously.

He noted that the non-response rate for the quadruple agonist is expected to be below 5%, with a weight loss rate of approximately 25%. The goal is to create a treatment that minimizes side effects such as muscle loss, offering a more effective and safer option for patients.

Chairman Seo projected that fourth-quarter sales would grow by 30% compared to the third quarter, with an operating profit margin exceeding 40%. He added that from the fourth quarter, Celltrion’s operating profit will enter a phase where it can compete with Samsung Biologics’ pre-split operating profit. This marks a significant milestone for the company as it continues to strengthen its position in the global pharmaceutical industry.

Comments

Post a Comment

Popular posts from this blog

Japan Firms Leverage Satellites and AI to Locate Abandoned Homes for Sale

-
Image
The Rise of AI-Powered Real Estate Discovery in Japan In Tokyo, a growing number of Japanese companies are leveraging satellite imagery and artificial intelligence to identify abandoned houses that could be repurposed or sold. This innovative approach is becoming increasingly vital as the country faces a rising number of deserted properties due to its aging population. Where Inc., a startup, offers a service that uses AI trained on tens of thousands of images to detect signs of aging roofs, such as rust and discoloration. These findings are then overlaid on satellite maps, helping users spot properties that may have been left unattended. One of Where Inc.'s users, Kotaro Yasue, recently discovered a two-story wooden house through this service. He was able to contact the owner via a real estate registry. It turned out that the house had been neglected for over a decade, and the owner was unsure how to proceed with its disposal. Yasue, who runs a house rental service company in G...
Read more

GEN Nigeria and Others Target Indigenous Firms with New Tech Fees

-
Image
Empowering Nigerian Entrepreneurs with AI Global Entrepreneurship Network (GEN Nigeria), in collaboration with Fidelity Bank Plc and other organizations, has called on young entrepreneurs in Nigeria to embrace new technologies, particularly Artificial Intelligence (AI), in their business operations. This initiative was highlighted during the Youth Entrepreneurship Dialogue, titled “Building the Future with AI: Technology, Talent, and Transformation Entrepreneurship,” which took place at the 2025 Global Entrepreneurship Week (GEW) in Lagos. Dr. Olawale Anifowose, the Managing Director of GEN Nigeria, emphasized that AI has become essential for local enterprises in Nigeria to boost productivity, drive innovation, and enhance competitiveness. According to Anifowose, this can be achieved by automating tasks, personalizing customer experiences through data analysis, and enabling entrepreneurs to develop and scale new products and services more efficiently. Enhancing Efficiency and Produc...
Read more

I Was Healthy Until a Dirty Habit Stopped My Heart

-
Image
A Rare Case of Cannabis-Induced Cardiac Arrest in a Young, Healthy Woman A 26-year-old woman from Georgia experienced a life-threatening cardiac arrest after smoking marijuana. The incident occurred when her fiancé discovered her unconscious on the bathroom floor, prompting immediate emergency medical intervention. Upon arrival at the hospital, doctors confirmed that she had suffered a cardiac arrest, where the heart suddenly stopped beating. The woman had no known pre-existing health conditions and tested negative for heart-related issues such as arrhythmia. However, she was found to have high levels of tetrahydrocannabinol (THC), the psychoactive compound in cannabis responsible for the "high" sensation. Doctors diagnosed her with ventricular fibrillation, a severe heart rhythm disorder that prevents the heart from effectively pumping blood and oxygen throughout the body. This led to what they described as a "cannabis-induced cardiac arrest." This case has rais...
Read more